Neurobiology of Disease

Interactions of A with Endogenous Anti-Inflammatory Agents: A Basis for Chronic Neuroinflammation in Alzheimer's Disease
pp. 187-200(14)
Authors: Janciauskiene S.; Sun Y-X.; Wright H.T.

An Inducible Mouse Model of Late Onset Tay–Sachs Disease
pp. 201-210(10)
Authors: Jeyakumar M.; Smith D.; Eliott-Smith E.; Cortina-Borja M.; Reinkensmeier G.; Butters T.D.; Lemm T.; Sandhoff K.; Perry V.H.; Dwek R.A.; Platt F.M.

Gene Expression Profiles in a Transgenic Animal Model of Fragile X Syndrome
pp. 211-218(8)
Authors: D'Agata V.; Warren S.T.; Zhao W.; Torre E.R.; Alkon D.L.; Cavallaro S.

Differential Neuroprotection by Cyclosporin A and FK506 Following Ischemia Corresponds with Differing Abilities to Inhibit Calcineurin and the Mitochondrial Permeability Transition
pp. 219-233(15)
Authors: Uchino H.; Minamikawa-Tachino R.; Kristián T.; Perkins G.; Narazaki M.; Siesjö B.K.; Shibasaki F.

The Modulation of Cellular Susceptibility to Oxidative Stress: Protective and Destructive Actions of Cu,Zn-Superoxide Dismutase
pp. 234-246(13)
Authors: Xing J.; Yu Y.; Rando T.A.

Status Epilepticus Induces Changes in the Expression and Localization of Endogenous Palmitoyl-Protein Thioesterase 1
pp. 247-257(11)
Authors: Suopanki J.; Lintunen M.; Lahtinen H.; Haltia M.; Panula P.; Baumann M.; Tyynelä J.

-Amyloid Fragment 25–35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons
pp. 258-267(10)
Authors: Casley C.S.; Land J.M.; Sharpe M.A.; Clark J.B.; Duchen M.R.; Canevari L.

Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
pp. 268-278(11)
Authors: Kriz J.; Nguyen M.D.; Julien J-P.

Oxidative Stress Increases Expression and Activity of BACE in NT₂ Neurons
pp. 279-288(10)
Authors: Tamagno E.; Bardini P.; Obbili A.; Vitali A.; Borghi R.; Zaccheo D.; Pronzato M.A.; Danni O.; Smith M.A.; Perry G.; Tabaton M.

Comparison of Calpain and Caspase Activities in the Adult Rat Brain after Transient Forebrain Ischemia
pp. 289-305(17)
Authors: Zhang C.; Siman R.; Xu Y.A.; Mills A.M.; Frederick J.R.; Neumar R.W.

Disruption of the Blood–Brain Barrier and Neuronal Cell Death in Cingulate Cortex, Dentate Gyrus, Thalamus, and Hypothalamus in a Rat Model of Gulf-War Syndrome
pp. 306-326(21)
Authors: Abdel-Rahman A.; Shetty A.K.; Abou-Donia M.B.

CuZn-Superoxide Dismutase in D90A Heterozygotes from Recessive and Dominant ALS Pedigrees
pp. 327-333(7)
Authors: Jonsson P.A.; Bäckstrand Å.; Andersen P.M.; Jacobsson J.; Parton M.; Shaw C.; Swingler R.; Shaw P.J.; Robberecht W.; Ludolph A.C.; Siddique T.; Skvortsova V.I.; Marklund S.L.

Abused Drugs Modulate RGS4 mRNA Levels in Rat Brain: Comparison Between Acute Drug Treatment and a Drug Challenge after Chronic Treatment
pp. 334-343(10)
Authors: Bishop G.B.; Cullinan W.E.; Curran E.; Gutstein H.B.

Delayed Clinical and Pathological Signs in Twitcher (Globoid Cell Leukodystrophy) Mice on a C57BL/6 × CAST/Ei Background
pp. 344-357(14)
Authors: Biswas S.; Biesiada H.; Williams T.D.; LeVine S.M.

Nogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis
pp. 358-365(8)
Authors: Dupuis L.; Gonzalez de Aguilar J-L.; di Scala F.; Rene F.; de Tapia M.; Pradat P-F.; Lacomblez L.; Seihlan D.; Prinjha R.; Walsh F.S.; Meininger V.; Loeffler J-P.

Up-Regulation of FPR2, a Chemotactic Receptor for Amyloid 1–42 (A₄₂), in Murine Microglial Cells by TNF
pp. 366-377(12)
Authors: Cui Y.H.; Le Y.; Zhang X.; Gong W.; Abe K.; Sun R.; Van Damme J.; Proost P.; Wang J.M.

Pyramidal Cell Loss in Motor Cortices in Huntington's Disease
pp. 378-386(9)
Authors: Macdonald V.; Halliday G.

Experimental Parkinsonism Modulates Multiple Genes Involved in the Transduction of Dopaminergic Signals in the Striatum
pp. 387-395(9)
Authors: Napolitano M.; Centonze D.; Calce A.; Picconi B.; Spiezia S.; Gulino A.; Bernardi G.; Calabresi P.

Ethanol-Induced Death of Postnatal Hippocampal Neurons
pp. 396-409(14)
Authors: Moulder K.L.; Fu T.; Melbostad H.; Cormier R.J.; Isenberg K.E.; Zorumski C.F.; Mennerick S.

Striatal and Cortical Neurochemical Changes Induced by Chronic Metabolic Compromise in the 3-Nitropropionic Model of Huntington's Disease
pp. 410-426(17)
Authors: Blum D.; Galas M-C.; Gall D.; Cuvelier L.; Schiffmann S.N.

Author Index for Volume 10
pp. 427-428(2)